<a href="https://laohu8.com/S/COCH">Envoy Medical Inc.</a> Conducted Annual Stockholders Meeting
Envoy Medical Inc. held its 2025 Annual Meeting of Stockholders on May 28, 2025. During the meeting, stockholders elected two Class II director nominees to the Board of Directors. The appointment of Grant Thornton LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified. An amendment to the Envoy Medical, Inc. 2023 Equity Incentive Plan was approved, removing the restriction on 1,500,000 shares of common stock previously unavailable for issuance until a regulatory milestone was achieved.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Envoy Medical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-050758), on June 03, 2025, and is solely responsible for the information contained therein.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。